Your browser doesn't support javascript.
loading
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Alvarez, Edwin A; Brady, William E; Walker, Joan L; Rotmensch, Jacob; Zhou, Xun C; Kendrick, James E; Yamada, S Diane; Schilder, Jeanne M; Cohn, David E; Harrison, Charles R; Moore, Kathleen N; Aghajanian, Carol.
Affiliation
  • Alvarez EA; Dept. of Reproductive Medicine, Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA 92093, USA. edwin.alvarez@ucdmc.ucdavis.edu
Gynecol Oncol ; 129(1): 22-7, 2013 Apr.
Article in En | MEDLINE | ID: mdl-23262204
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Endometrial Neoplasms / Sirolimus / Antibodies, Monoclonal, Humanized / Neoplasm Recurrence, Local Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Endometrial Neoplasms / Sirolimus / Antibodies, Monoclonal, Humanized / Neoplasm Recurrence, Local Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2013 Document type: Article Affiliation country: Country of publication: